• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-K filed by Dynatronics Corporation

    9/26/25 12:23:08 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care
    Get the next $DYNT alert in real time by email
    NT 10-K 1 formnt10k.htm FORM NT 10-K Dynatronics Corp.: Form NT 10-K - Filed by newsfilecorp.com

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    FORM 12b-25

    NOTIFICATION OF LATE FILING

    (Check one):

     
       
       
     

    SEC FILE NUMBER
    000-12697

       
     

    CUSIP NUMBER
    268157500

    [ x ] Form 10-K    [           ] Form 20-F    [           ] Form 11-K
    [           ] Form 10-Q    [           ] Form 10-D    [           ] Form N-CEN    [           ] Form N-CSR

    For Period Ended: June 30, 2025

    [           ] Transition Report on Form 10-K
    [           ] Transition Report on Form 20-F
    [           ] Transition Report on Form 11-K
    [           ] Transition Report on Form 10-Q

    For the Transition Period Ended:

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

    PART I — REGISTRANT INFORMATION

    DYNATRONICS CORP.
    Full Name of Registrant

    N/A
    Former Name if Applicable

    1200 Trapp Road
    Address of Principal Executive Office (Street and Number)

    Eagan, MN, 55121
    City, State and Zip Code


    PART II — RULES 12b-25(b) AND (c)

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

    x (a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
       
    (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
       
    (c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

    PART III — NARRATIVE

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

    Dynatronics Corporation (the "Company") is unable to file its Annual Report on Form 10-K for the fiscal year ended June 30, 2025 within the prescribed time period. The delay, which could not be eliminated without unreasonable effort or expense, is due to the additional time required to complete an impairment analysis that is necessary to finalize the financial statements and related disclosures included in the Form 10-K. The Company is working diligently to complete this analysis and expects to file the Form 10-K within the extension period allowed under Rule 12b-25.

    PART IV — OTHER INFORMATION

    (1) Name and telephone number of person to contact in regard to this notification

      Brian Baker 760 473-2591
      (Name) (Area Code) (Telephone Number)

    (2)

    Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).

    [ x ] Yes [           ] No
       
    (3)

    Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

    [           ] Yes [ x ] No

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

    DYNATRONICS CORP.
    (Name of Registrant as Specified in Charter)

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

    Date: September 26, 2025 By: /s/ Brian Baker
        Brian Baker
      Title: Chief Executive Officer & Chief Financial Officer


    Get the next $DYNT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DYNT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DYNT
    SEC Filings

    View All

    SEC Form NT 10-K filed by Dynatronics Corporation

    NT 10-K - DYNATRONICS CORP (0000720875) (Filer)

    9/26/25 12:23:08 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Dynatronics Corporation

    10-Q - DYNATRONICS CORP (0000720875) (Filer)

    5/12/25 4:00:27 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Corporation filed SEC Form 8-K: Leadership Update

    8-K - DYNATRONICS CORP (0000720875) (Filer)

    5/9/25 8:00:26 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $DYNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

    Leixir Dental Laboratory Group (Leixir), a leading operator of a full-service, state-of-the-art dental laboratory network, today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier succeeds Leixir founder Harmeet Bindra, who will continue as Executive Chairman. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries. He joins Leixir from Dynatronics Corporation (NASDAQ:DYNT), where he was most recently President and CEO. Before that, he held senior roles in corporate strategy and commercial execution, including marketing and customer experience, over seven

    1/8/24 8:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Appointment of Dr. Christopher von Jako as new CEO

    Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company's Board of Directors has appointed Christopher von Jako, Ph.D. ("Dr. von Jako") as Chief Executive Officer and director of the Company, effective immediately. Dr. von Jako succeeds Richard Hullihen, who will be retiring and will be stepping down as a Director of the Company, effective immediately. Mr. Hullihen will assist the Company in a transitional position for the next six months. Since his appointment as CEO in 2017, Richard has overseen significant progress for Polarean. He led the Company through its successful IPO in 2018 and over $60M of ca

    6/21/23 9:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

    Consistency of Executive Leadership Expected to Provide Smooth TransitionEagan, Minnesota--(Newsfile Corp. - May 18, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional interests. Brian Baker, the company's current Chief Operating Officer, and former President and Chief Executive Officer, has accepted the role of President of Dynatronics effective immediately and will assume the titles of President, Chief Executive

    5/18/23 8:05:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    President & CEO, CFO Baker Brian D. acquired 80,898 shares, increasing direct ownership by 27% to 381,545 units (SEC Form 4)

    4 - DYNATRONICS CORP (0000720875) (Issuer)

    10/3/25 11:46:26 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Large owner Essig Stuart acquired 1,153,461 shares, increasing direct ownership by 27% to 4,520,419 units (SEC Form 4)

    4 - DYNATRONICS CORP (0000720875) (Issuer)

    10/3/25 8:11:50 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Director Enright Erin S. acquired 1,153,461 shares (SEC Form 4)

    4 - DYNATRONICS CORP (0000720875) (Issuer)

    10/3/25 8:01:50 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    Leadership Updates

    Live Leadership Updates

    View All

    Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

    Leixir Dental Laboratory Group (Leixir), a leading operator of a full-service, state-of-the-art dental laboratory network, today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier succeeds Leixir founder Harmeet Bindra, who will continue as Executive Chairman. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries. He joins Leixir from Dynatronics Corporation (NASDAQ:DYNT), where he was most recently President and CEO. Before that, he held senior roles in corporate strategy and commercial execution, including marketing and customer experience, over seven

    1/8/24 8:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Appointment of Dr. Christopher von Jako as new CEO

    Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company's Board of Directors has appointed Christopher von Jako, Ph.D. ("Dr. von Jako") as Chief Executive Officer and director of the Company, effective immediately. Dr. von Jako succeeds Richard Hullihen, who will be retiring and will be stepping down as a Director of the Company, effective immediately. Mr. Hullihen will assist the Company in a transitional position for the next six months. Since his appointment as CEO in 2017, Richard has overseen significant progress for Polarean. He led the Company through its successful IPO in 2018 and over $60M of ca

    6/21/23 9:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

    Consistency of Executive Leadership Expected to Provide Smooth TransitionEagan, Minnesota--(Newsfile Corp. - May 18, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional interests. Brian Baker, the company's current Chief Operating Officer, and former President and Chief Executive Officer, has accepted the role of President of Dynatronics effective immediately and will assume the titles of President, Chief Executive

    5/18/23 8:05:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    Financials

    Live finance-specific insights

    View All

    Dynatronics Corporation Reports Third Quarter Fiscal Year 2023 Financial Results and Business Highlights

    Eagan, Minnesota--(Newsfile Corp. - May 11, 2023) - Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its third quarter of fiscal year 2023 ended March 31, 2023, and provided an update on the business.CEO Commentary"Dynatronics experienced revenue challenges in our third fiscal quarter as a result of three external factors. As a result, we are adjusting our spending and revenue expectations as we respond to the specific impacts of:Competitive acquisitions by a significant rehabilitation customer; Reduction in specific SKUs of an OEM customer for the

    5/11/23 7:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Corporation Schedules Conference Call to Report Third Quarter Results for Fiscal 2023

    Eagan, Minnesota--(Newsfile Corp. - April 27, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its third quarter of fiscal year 2023 on Thursday, May 11, 2023 before the market opens.The company will subsequently hold a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session with analysts, at 8:00 AM ET on Thursday, May 11, 2023, to review its third quarter results.Interested persons may access the live conference call by dialing 1-800-319-4610 (U.S./Canada calle

    4/27/23 8:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Corporation Reports Second Quarter Fiscal Year 2023 Financial Results and Business Highlights

    EAGAN, MN / ACCESSWIRE / February 9, 2023 / Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its second quarter of fiscal year 2023 ended December 31, 2022, and provided an update on the business.CEO Commentary"The year-over-year improvement in gross margin of 8.4% or nearly $1.0 million in gross profit was a solid improvement. We are pleased with our progression, but we have more work to do. New, targeted, and innovative, product releases are the third pillar of our gross margin improvement plan, and we plan to continue to improve our performance in

    2/9/23 7:30:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

    SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

    2/14/23 12:35:29 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

    SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

    2/13/23 12:33:51 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

    SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

    1/14/22 12:22:28 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care